BRILIFE

VSV-ΔG SARS-CoV-2 vaccine · NeuroRx, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BRILIFE, covering 2024-01-19 to 2024-01-19. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine. [Phase 2, Phase 3]